Patterns of care and survival for adolescents and young adults with acute leukaemia--a population-based study (Q36618262)

15 August 2017

Patterns of care and survival for adolescents and young adults with acute leukaemia--a population-based study (English)

1 reference

15 August 2017

1 reference

1 reference

1

Stiller CA

1 reference

15 August 2017

Benjamin S

2

1 reference

15 August 2017

Cartwright RA

3

1 reference

15 August 2017

Clough JV

4

1 reference

15 August 2017

Gorst DW

5

1 reference

15 August 2017

Kroll ME

6

1 reference

15 August 2017

Ross JR

7

1 reference

15 August 2017

Wheatley K

8

1 reference

15 August 2017

Whittaker JA

9

1 reference

15 August 2017

Taylor PR

10

1 reference

15 August 2017

Proctor SJ

11

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

79

1 reference

15 August 2017

3-4

1 reference

15 August 2017

658-665

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6690104

15 August 2017

0 references

cites work

Benefits from specialised cancer care

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362441

Survival from acute non-lymphocytic leukaemia, 1971-88: a population based study.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362441

Centralised treatment, entry to trials and survival

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362441

Population based survival rates for childhood cancer in Britain, 1980-91.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362441

Acute lymphoblastic leukaemia in adults: the case for a strategic shift in study approach

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362441

Treatment and survival of lymphoid malignancy in the north-west of England: a population-based study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362441

Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362441

Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362441

Delivering cancer care: a model from the West Midlands

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362441

Establishing cancer units

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362441

Acute lymphoblastic leukaemia in adults in the northern region of England--a study of 75 cases

28 June 2018

1 reference

12 December 2020

The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties

1 reference

12 December 2020

Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)

1 reference

12 December 2020

Evaluation of the impact of allogenic transplant in first remission on an unselected population of patients with acute myeloid leukaemia aged 15-55 years. The Northern Regional Haematology Group

1 reference

12 December 2020

Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the

1 reference

12 December 2020

Two subsets of peripheral blood plasma cells defined by differential expression of CD45 antigen

1 reference

12 December 2020

Population-based survival trends for leukaemia in East Anglia, United Kingdom

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690104

7 January 2021

The PACE (population-adjusted clinical epidemiology) strategy: a new approach to multi-centred clinical research

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690104

7 January 2021

Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690104

7 January 2021

Intensification of treatment for adults with acute lymphoblastic leukaemia: results of U.K. Medical Research Council randomized trial UKALL XA. Medical Research Council Working Party on Leukaemia in Adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690104

7 January 2021

Estimated 8-year survival of more than 40% in a population-based study of 79 adult patients with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690104

7 January 2021

Survival in adult leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690104

7 January 2021

Intensive induction and consolidation chemotherapy for adults and children with acute myeloid leukaemia (AML) joint AML trial 1982-1985

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690104

7 January 2021

Young adults 16-21 years of age at diagnosis entered on Childrens Cancer Group acute lymphoblastic leukemia and acute myeloblastic leukemia protocols. Results of treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690104

7 January 2021

Dose intensification in acute myeloid leukaemia: greater effectiveness at lower cost. Principal report of the Medical Research Council's AML9 study. MRC Leukaemia in Adults Working Party

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690104

7 January 2021

Identifiers

DOI

10.1038/SJ.BJC.6690104

1 reference

15 August 2017

1 reference

15 August 2017

1 reference